medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2013, Number 5

<< Back Next >>

Ann Hepatol 2013; 12 (5)

Syncope during boceprevir treatment in hepatitis C

Ridruejo E, Silva MO, Mandó OG

Language: English
References: 10
Page: 837-838
PDF size: 56.10 Kb.


Text Extraction

Dear Editor:
Recently, the standard of care (SoC) of chronic hepatitis C virus (HCV) infection has changed, and HCV treatment has entered a new era with the introduction of direct-acting antiviral agents (DAAs). Combination therapy with pegylated interferon (pegIFN) and ribavirin (RBV) and the two first generation NS3/4A protease inhibitors (PI) –telaprevir (TVR) and boceprevir (BOC)– has been approved in many countries.


REFERENCES

  1. Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB; American Association for Study of Liver Diseases. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011; 54: 1433-44.

  2. Chávez-Tapia NC, Ridruejo E, Alves de Mattos A, Bessone F, Daruich J, Sánchez-Ávila JF, Cheinquer H, et al. An update on the management of hepatitis C: guidelines for protease inhibitor-based triple therapy from the Latin American Association for the Study of the Liver. Ann Hepatol 2013; Suppl. 2: 3-35.

  3. Silva MO, Ridruejo E, Galdame O, Bessone F, Colombato L, Daruich J, Fainboim H, et al. Asociación Argentina para el Estudio de las Enfermedades del Hígado. Recommendations for the treatment of chronic genotype 1 hepatitis C virus infection. Acta Gastroenterol Latinoam 2012; 42: 234-49.

  4. Poordad F, McCone JJ, Bacon BR, Bruno S, Manns MP, Sulkowski MS, Jacobson IM, et al. Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med 2011; 364: 1195-206.

  5. Jacobson IM, McHutchison JG, Dusheiko G, Di Bisceglie AM, Reddy KR, Bzowej NH, Marcellin P, et al. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med 2011; 364: 2405-16.

  6. Bacon BR, Gordon SC, Lawitz E, Marcellin P, Vierling JM, Zeuzem S, Poordad F, et al. Boceprevir for previously treated chronic HCV genotype 1 infection. N Engl J Med 2011; 364: 1207-17.

  7. Zeuzem S, Andreone P, Pol S, Lawitz E, Diago M, Roberts S, Focaccia R, et al. Telaprevir for retreatment of HCV infection. N Engl J Med 2011; 364: 2417-28.

  8. Pegasys prescribing information.

  9. Pegintron prescribing information.

  10. http://www.hepatitis.va.gov/provider/guidelines/ 2012HCV-supplement-table2.asp.




2020     |     www.medigraphic.com